U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06798623) titled 'Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells' on Jan. 20.
Brief Summary: This study is designed as a prospective, open label, single arm pilot clinical study that will establish the safety and efficacy of a single injection of mesenchymal stromal cells in patients. Each subject will receive one intra-articular injection of autologous mesenchymal stromal cells derived from infrapatellar fat pad (FP-MSC) tissue samples collected from the subject during anterior cruciate ligament (ACL) reconstruction surgery.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:...